Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study
Clinical trial NCT01237340 · TERMINATED
Trial details
- NCT number
- NCT01237340
- Sponsor
- EMD Serono
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-12-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.